News
AIPPI has pulled the plug on its planned 2027 World Congress, and INTA has seemingly committed to hosting a meeting there, but the concerns won’t abate
Despite being outspent by a wealthy opponent, a trial attorney at King & Spalding says ‘relentless pursuit of the truth’ helped his team secure a $420m damages award for mobile gaming client
190 drugs face loss of exclusivity between 2026 and 2030, with the list including Bristol Myers Squibb’s blood-thinning drug Eliquis and immunotherapy medication Opdivo
Nokia, represented by a team from Bird & Bird, adjudged to have made fair offer to Asus and Acer in UK SEP dispute
Sponsored
Sponsored
-
Sponsored by IncoproIncopro’s report highlights how e-commerce platforms can protect consumers from repeat offenders and why a uniform approach is needed to significantly reduce illicit sales -
Sponsored by IncoproMike Sweeney and Chloe Lee of Incopro discuss how legislative changes ahead will have an impact on the way online marketplaces operate
-
Sponsored by IncoproKimiya Shams, legal counsel at audio tech company Devialet, discusses her growth as an IP lawyer and looks at how brand protection programmes serve to safeguard consumers and brand owners
-
Sponsored by IncoproHosted by Managing IP’s Ed Conlon, the discussion at Incopro’s Insync Virtual Summit explored how the pandemic has affected brand protection teams and offered key insights to drive success in 2021
-
Sponsored by IncoproColette Durst explains how she restructured the 3M team during COVID and why a pandemic is the perfect time to show IP worth
-
Sponsored by Bird & BirdMax Walters joins Sally Shorthose and James Baillieu of Bird & Bird and Henry Hadad of Bristol Myers Squibb to discuss how COVID-19 has shaped transactional work
